NCT01428622 - Olodaterol Bridging Study in Asthma | Biotech Hunter

Timeline

Start Date

October 31, 2011

Conditions

Asthma

Interventions

DEVICE

Respimat

aqueous and ethanolic solution

DEVICE

Respimat

aqueous and ethanolic solution

DEVICE

Respimat

aqueous and ethanolic solution

DEVICE

Respimat

aqueous and ethanolic solution

DEVICE

Respimat

aqueous and ethanolic solution

DEVICE

Respimat

aqueous and ethanolic solution

DEVICE

Respimat

aqueous and ethanolic solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol

aqueous solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

Olodaterol & BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

DRUG

BI54903

ethanolic solution

Trial Locations (1)

Unknown

1249.7.33003 Boehringer Ingelheim Investigational Site, Gières